| Application no. and date | 20181431.6 (espacenet) (Federated) (European Patent Register), 20151119 | | Patent/reg. no. and date | DK/EP 3733235, 20230614 | | Publication date | 20201104 | | Priority no. and date | US 201462081742 P, 20141119 | | EP pub. no. and date |
EP 3733235 20201104 | | Effective date | | | Applicant/owner | OPTINOSE, INC., 1020 Stony Hill Road, Ste 300
Yardley, PA 19067, US | | Applicant ref. no. | | | Inventor | DJUPESLAND, Per Gisle, c/o OptiNose AS
Postboks 288 Røa
0702 Oslo, NO,
SHELDRAKE, Colin David, c/o OptiNose UK Ltd.
Berkeley House
Hunts Rise
South Marston Park, Wiltshire SN3 4TG, GB | | Representative | | | Opponent | | | IPC Class | A61M 15/00 (2006.01) , A61M 15/08 (2006.01) | | Title | INTRANASAL ADMINISTRATION | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
